Alliance for Innovation on Maternal Health (AIM) is a national partnership of provider, public health and advocacy organizations. AIM works through state teams and health systems to align national, state, and hospital level quality improvement efforts to better overall maternal health outcomes. The goal is to eliminate preventable maternal mortality and severe morbidity across the United States.

AIM states focus on reducing maternal mortality through implementation of maternal safety "bundles," or evidence-informed toolkits. 

Addressing Substance Use Across The Perinatal Period
Addressing Substance Use Across The Perinatal Period
The AIM OUD Bundle adds several new components to the Perinatal Opioid Project, a PNQIN initiative that focuses on the effects of substance use from pregnancy to infancy.

AIM Opioid Bundle

Massachusetts Maternal Mortality and Morbidity Review Committee findings indicate that during 2005-2014 one in five pregnancy-associated deaths (20.6%; n=41) was related to substance use. An increasing trend in the proportion of substance use-related deaths was observed over this period, from 8.7% in 2005 to 41.4% in 2014. This trend is consistent with the increase in opioid overdose deaths in Massachusetts overall during the same time period. Therefore, PNQIN is prioritizing the Obstetric Care for Women with Opioid Use Disorder bundle in its initial AIM rollout. 

This particular AIM bundle builds on PNQIN’s Opioid Project, a statewide project focused on improving the care of opioid-exposed newborns and their families, which has brought together over 30 Massachusetts hospitals, numerous community groups, and multiple state agencies in structured, collaborative improvement efforts, with a twice-yearly statewide summit that anchors the project.